On the other hand, emerging involvement of heparanase in diabetes, including its role in the islet/beta cell damage (32, 78–80), taken together with augmented production of the enzyme by pancreatic carcinoma cells under hyperglycemic conditions (this study), implies that the enzyme may exacerbate PDAC-associated diabetes. Here, HPSE is linked to exocrine pancreatic carcinoma.